ANNALIESE MAJEED: Open Payments
NPI 1528558087 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,669 in 110 payments from 26 companies in 2025. Trend: 2023 $4,258 · 2024 $5,423 · 2025 $2,669
Food & beverage: $2,328Education: $341
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $513 |
| ABBVIE INC. | 13 | $326 |
| Galderma Laboratories, L.P. | 12 | $279 |
| Regeneron Healthcare Solutions, Inc. | 9 | $215 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $208 |
| Amgen Inc. | 7 | $162 |
| Novartis Pharmaceuticals Corporation | 8 | $146 |
| Organon LLC | 1 | $125 |
| Lilly USA, LLC | 4 | $101 |
| Daiichi Sankyo Inc. | 4 | $83 |
Products named: TREMFYA, NEMLUVIO, DUPIXENT, RINVOQ, OTEZLA, VTAMA, RYBREVANT, PLUVICTO.
Industry payments across TX — which companies pay providers there.
